Zampaletta C - Search Results

1

Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study.

Mocci G, Tursi A, Maconi G, Cataletti G, Mantia B, Serio M, Scarcelli A, Pagnini C, Graziani MG, Di Paolo MC, Pranzo G, Luppino I, Paese P, Elisei W, Monterubbianesi R, Faggiani R, Ferronato A, Perini B, Savarino E, Onidi FM, Binaghi L, Usai Satta P, Schiavoni E, Napolitano D, Scaldaferri F, Pugliese D, Pica R, Cocco A, Zippi M, Rodino S, Sebkova L, Rocco G, Sacchi C, Zampaletta C, Gaiani F, De Angelis G, Kayali S, Fanigliulo L, Lorenzetti R, Allegretta L, Scorza S, Cuomo A, Donnarumma L, Della Valle N, Sacco R, Forti G, Antonelli E, Bassotti G, Iannelli C, Luzza F, Aragona G, Perazzo P, Lauria A, Piergallini S, Colucci R, Bianco MA, Meucci C, Giorgetti G, Clemente V, Fiorella S, Penna A, De Medici A, Picchio M, Papa A. Mocci G, et al. Among authors: zampaletta c. Expert Opin Biol Ther. 2023 Mar;23(3):293-304. doi: 10.1080/14712598.2023.2185510. Epub 2023 Mar 2. Expert Opin Biol Ther. 2023. PMID: 36843568

2

Spontaneous right ventricular thrombus in a patient with active ulcerative colitis and protein C deficiency: a review with a case report.

Urgesi R, Zampaletta C, Masini A, Pelecca G, Pastorelli A, De Lorenzo A, Faggiani R. Urgesi R, et al. Among authors: zampaletta c. Eur Rev Med Pharmacol Sci. 2010 May;14(5):455-63. Eur Rev Med Pharmacol Sci. 2010. PMID: 20556925 Review.

3

Helicobacter pylori infection: is sequential therapy superior to standard triple therapy? A single-centre Italian study in treatment-naive and non-treatment-naive patients.

Urgesi R, Pelecca G, Cianci R, Masini A, Zampaletta C, Riccioni ME, Faggiani R. Urgesi R, et al. Among authors: zampaletta c. Can J Gastroenterol. 2011 Jun;25(6):315-8. doi: 10.1155/2011/967671. Can J Gastroenterol. 2011. PMID: 21766091 Free PMC article.

4

Effectiveness and safety of infliximab and adalimumab for ambulatory Crohn's disease patients in primary gastroenterology centres.

Tursi A, Elisei W, Picchio M, Penna A, Lecca PG, Forti G, Giorgetti G, Faggiani R, Zampaletta C, Pelecca G, Brandimarte G. Tursi A, et al. Among authors: zampaletta c. Eur J Intern Med. 2014 Jun;25(5):485-90. doi: 10.1016/j.ejim.2014.02.010. Epub 2014 Mar 13. Eur J Intern Med. 2014. PMID: 24631020

5

Letter: diverticulosis in inflammatory bowel diseases.

Tursi A, Elisei W, Picchio M, Forti G, Giorgetti G, Faggiani R, Zampaletta C, Brandimarte G. Tursi A, et al. Among authors: zampaletta c. Aliment Pharmacol Ther. 2014 Apr;39(8):899-900. doi: 10.1111/apt.12656. Aliment Pharmacol Ther. 2014. PMID: 24635315 No abstract available.

6

Comparison of the effectiveness of infliximab and adalimumab in preventing postoperative recurrence in patients with Crohn's disease: an open-label, pilot study.

Tursi A, Elisei W, Picchio M, Zampaletta C, Pelecca G, Faggiani R, Brandimarte G. Tursi A, et al. Among authors: zampaletta c. Tech Coloproctol. 2014 Nov;18(11):1041-6. doi: 10.1007/s10151-014-1177-1. Epub 2014 Jun 12. Tech Coloproctol. 2014. PMID: 24915941 Clinical Trial.

7

Letter: infliximab vs. adalimumab in treating ambulatory perianal fistulising Crohn's disease.

Tursi A, Elisei W, Picchio M, Zampaletta C, Faggiani R, Brandimarte G. Tursi A, et al. Among authors: zampaletta c. Aliment Pharmacol Ther. 2014 Jul;40(2):218-20. doi: 10.1111/apt.12828. Aliment Pharmacol Ther. 2014. PMID: 24946069 No abstract available.

8

Managing ambulatory ulcerative colitis patients with infliximab: a long term follow-up study in primary gastroenterology centers.

Tursi A, Elisei W, Picchio M, Penna A, Lecca PG, Forti G, Giorgetti G, Faggiani R, Zampaletta C, Pelecca G, Brandimarte G. Tursi A, et al. Among authors: zampaletta c. Eur J Intern Med. 2014 Oct;25(8):757-61. doi: 10.1016/j.ejim.2014.07.007. Epub 2014 Jul 30. Eur J Intern Med. 2014. PMID: 25086677

9

Effectiveness of adalimumab for ambulatory ulcerative colitis patients after failure of infliximab treatment: a first "real-life" experience in primary gastroenterology centers in Italy.

Tursi A, Elisei W, Picchio M, Penna A, Forti G, Giorgetti GM, Faggiani R, Zampaletta C, Pelecca G, Brandimarte G. Tursi A, et al. Among authors: zampaletta c. Ann Gastroenterol. 2014;27(4):369-373. Ann Gastroenterol. 2014. PMID: 25331091 Free PMC article.

10

Development and validation of an endoscopic classification of diverticular disease of the colon: the DICA classification.

Tursi A, Brandimarte G, Di Mario F, Andreoli A, Annunziata ML, Astegiano M, Bianco MA, Buri L, Cammarota G, Capezzuto E, Chilovi F, Cianci M, Conigliaro R, Del Favero G, Di Cesare L, Di Fonzo M, Elisei W, Faggiani R, Farroni F, Forti G, Germanà B, Giorgetti GM, Giovannone M, Lecca PG, Loperfido S, Marmo R, Morucci P, Occhigrossi G, Penna A, Rossi AF, Spadaccini A, Zampaletta C, Zilli M, Zullo A, Scarpignato C, Picchio M. Tursi A, et al. Among authors: zampaletta c. Dig Dis. 2015;33(1):68-76. doi: 10.1159/000366039. Epub 2014 Dec 17. Dig Dis. 2015. PMID: 25531499

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters